Cart
sales@molnova.com
BRL 50481
CAS No. 433695-36-4
BRL 50481 ( —— )
Catalog No. M19908 CAS No. 433695-36-4
BRL-50481 is a novel and selective inhibitor of PDE7 with IC50s of 0.15 12.1 62 and 490 μM for PDE7A PDE7B PDE4 and PDE3 respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 54 | In Stock |
|
| 25MG | 113 | In Stock |
|
| 50MG | 203 | In Stock |
|
| 100MG | 340 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBRL 50481
-
NoteResearch use only not for human use.
-
Brief DescriptionBRL-50481 is a novel and selective inhibitor of PDE7 with IC50s of 0.15 12.1 62 and 490 μM for PDE7A PDE7B PDE4 and PDE3 respectively.
-
DescriptionBRL-50481 is a novel and selective inhibitor of PDE7 with IC50s of 0.15 12.1 62 and 490 μM for PDE7A PDE7B PDE4 and PDE3 respectively.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE7
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number433695-36-4
-
Formula Weight244.27
-
Molecular FormulaC9H12N2O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 100 mg/mL;Ethanol: 20 mg/mL
-
SMILESCN(C)S(=O)(=O)c1cc(ccc1C)[N+]([O-])=O
-
Chemical NameNN2-Trimethyl-5-nitro-benzenesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Safavi M et al. New methods for the discovery and synthesis of PDE7 inhibitors as new drugs for neurologicaland inflammatory disorders. Expert Opin Drug Discov. 2013 Jun;8(6):733-51.
molnova catalog
related products
-
Trequinsin hydrochlo...
Trequinsin hydrochloride (HL 725) is a potent, cell-permeable, orally active inhibitor of cGMP-inhibited phosphodiesterase (PCE3 IC50=250 pM).
-
Difamilast
Difamilast (OPA-15406) is a novel potent, selective phosphodiesterase IV (PDE4) inhibitor with preference for PDE4B (IC50=11.2 nM).
-
Zomepirac Sodium
Zomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions.
